References
- KerbelRSClinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial resultsJ Clin Oncol20011945S51S11560971
- ArmitageJOLeukeran (chlorambucil)Current Clinical Guide2nd edNew York, NYWellcome Oncology NCM19933745
- FarmerPRMetabolism and reactions of alkylating agentsPharmacol Ther1987353013324117
- AlbertssonPLennernasBNorrbyKChemotherapy and antiangiogenesis: drugspecific effects on microvessel sproutingAPMIS2003111995100314629265
- ShakedYEmmeneggerUManSOptimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activityBlood20051063058306115998832
- TonMNChangCCarpentierYADeckelbaumRJIn vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglyceridesClin Nutr20052449250116054521
- ZhigaltsevIVMaurerNLiposome-encapsulated vincristine, vinblastine and vinorelbine: A comparativie study of drug loading and retentionJ Control Release2005410311115866338
- PugliaCBlasiPRizzaLLipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigationInt J Pharm200835729530418343059
- SaupeAGordonKCRadesTStructural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopyInt J Pharm200614566216574354
- MullerRHRadtkeMWissingSANanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm200224212112812176234
- JenningVThunemannAFGohlaSHCharacterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInt J Pharm200019916717710802410
- SekiJSasakiHDoiMLipid nano-sphere (LNS), a protein-free analog of lipoproteins, as a novel drug carrier for parenteral administration. IVJ Control Release199428352353
- WissingSAKayserOMullerRHSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev2004561257127215109768
- GantaSPaxtonJWBaguleyBCGargSPharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsionInt J Pharm200836011512118508212
- BockTKLucksJSKleinebuddePMullerRHMullerBWHigh-pressure homogenization of parenteral fat emulsions - influence of process parameters on emulsion qualityEur J Pharm Biopharm199440157160
- DipaliSRKulkarniSBBetageriGVComparative study of separation of non-encapsulated drug from unilamellar liposomes by various methodsJ Pharm Pharmacol199648111211158961156
- LeeFYCoePWorkmanPPharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in miceCancer Chemother Pharmacol19861721293698173
- WirtitschMWessnerBSpittlerAEffect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysisClin Nutr20072630231317449147
- TamilvananSOil-in-water lipid emulsions: implications for parenteral and ocular delivering systemsProg Lipid Res20044348953315522762
- BenitaSFriedmanDWeinstockMPhysostigmine emulsion - a new injectable controlled release delivery systemInt J Pharm1986304755
- HaweAFriessWImpact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulationsEur J Pharm Biopharm20066431632516875806
- LimSJKimCKFormulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acidInt J Pharm200224313514612176302
- ZimmermannEMullerRHMaderKInfluence of different parameters on reconstitution of lyophilized SLNInt J Pharm200019621121310699720
- BenitaSLevyMYSubmicron emulsions as colloidal drug carriers for intravenous administration - comprehensive physicochemical characterizationJ Pharm Sci199382106910798289116
- DongzhiHouChangshengXieThe production and characteristics of solid lipid nanoparticles (SLNs)Biomaterials2003241781178512593960
- SiekmannBWestesenKThermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticlesColloids Surf B Biointerfaces19943159175